Pathogenic amino acid substitutions of the common E3 component (hE3) of the human alpha-ketoglutarate dehydrogenase and the pyruvate dehydrogenase complexes lead to severe metabolic diseases (E3 deficiency), which usually manifest themselves in cardiological and/or neurological symptoms and often cause premature death. To date, 14 disease-causing amino acid substitutions of the hE3 component have been reported in the clinical literature. None of the pathogenic protein variants has lent itself to high-resolution structure elucidation by X-ray or NMR. Hence, the structural alterations of the hE3 protein caused by the disease-causing mutations and leading to dysfunction, including the enhanced generation of reactive oxygen species by selected ...
The Iowa point mutation in apolipoprotein A-I (G26R) leads to a systemic amyloidosis condition, and ...
G6PD deficiency, an enzymopathy affecting 7% of the world population, is caused by over 160 identifi...
This dissertation focuses on the use of mass spectrometry (MS) to study therapeutic protein higher o...
AbstractHuman dihydrolipoamide dehydrogenase (hLADH) is a flavoenzyme component (E3) of the human al...
This review summarizes our present view on the molecular pathogenesis of human (h) E3-deficiency cau...
We report the crystal structures of the human (dihydro)lipoamide dehydrogenase (hLADH, hE3) and its ...
SummaryThe 9.5 MDa human pyruvate dehydrogenase complex (PDC) utilizes the specific dihydrolipoamide...
Dihydrolipoamide dehydrogenase is a common component of mammalian multienzyme complexes that decarbo...
SummaryMost known disease-associated mutations are missense mutations involving changes of amino aci...
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterized by ...
Dihydrolipoamide dehydrogenase (LADH, E3) deficiency is a rare (autosomal, recessive) genetic disord...
Human dihydrolipoamide dehydrogenase (LADH, E3) is a component in the pyruvate-, alpha-ketoglutarate...
AbstractBackground: Mutations in components of the extraordinarily large α-ketoacid dehydrogenase mu...
The study of protein conformation by solution-phase hydrogen/deuterium exchange (HDX) coupled to MS ...
oxidoreductase; EC 1.8.1.4), along with glutathione reductase and trypanothione reductase, belongs t...
The Iowa point mutation in apolipoprotein A-I (G26R) leads to a systemic amyloidosis condition, and ...
G6PD deficiency, an enzymopathy affecting 7% of the world population, is caused by over 160 identifi...
This dissertation focuses on the use of mass spectrometry (MS) to study therapeutic protein higher o...
AbstractHuman dihydrolipoamide dehydrogenase (hLADH) is a flavoenzyme component (E3) of the human al...
This review summarizes our present view on the molecular pathogenesis of human (h) E3-deficiency cau...
We report the crystal structures of the human (dihydro)lipoamide dehydrogenase (hLADH, hE3) and its ...
SummaryThe 9.5 MDa human pyruvate dehydrogenase complex (PDC) utilizes the specific dihydrolipoamide...
Dihydrolipoamide dehydrogenase is a common component of mammalian multienzyme complexes that decarbo...
SummaryMost known disease-associated mutations are missense mutations involving changes of amino aci...
Dihydropyrimidine dehydrogenase (DPD) deficiency is an autosomal recessive disease characterized by ...
Dihydrolipoamide dehydrogenase (LADH, E3) deficiency is a rare (autosomal, recessive) genetic disord...
Human dihydrolipoamide dehydrogenase (LADH, E3) is a component in the pyruvate-, alpha-ketoglutarate...
AbstractBackground: Mutations in components of the extraordinarily large α-ketoacid dehydrogenase mu...
The study of protein conformation by solution-phase hydrogen/deuterium exchange (HDX) coupled to MS ...
oxidoreductase; EC 1.8.1.4), along with glutathione reductase and trypanothione reductase, belongs t...
The Iowa point mutation in apolipoprotein A-I (G26R) leads to a systemic amyloidosis condition, and ...
G6PD deficiency, an enzymopathy affecting 7% of the world population, is caused by over 160 identifi...
This dissertation focuses on the use of mass spectrometry (MS) to study therapeutic protein higher o...